Delivery Order SPE2DB20D1109-SPE2DB24FP60J

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,300.53, is for the delivery of the drug Sunosi (150 mg tablets) and has a completion date of February 28, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,166.56, is for the delivery of 150 mg tablets of the medication Sunosi, with a period of performance through March 2025. The contract is a firm-fixed price type with no set-aside designation, indicating open competition. Amerisourcebergen also holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.99 firm fixed price contract is for the supply of Sunosi 75 mg tablets to support military healthcare programs. The contract has a period of performance through January 31, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $4,088.10 with a firm fixed price. The contract is for the delivery of SUNOSI 150 MG TABLET 30S, a pharmaceutical product, with a period of performance through December 31, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SUNOSI 75 MG TABLET 30S. The award, valued at $1,299.54, is a firm fixed-price contract with a completion date of July 26, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical products and medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,600.17 for the supply of Sunosi 150 mg tablets. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,313.29, is for the delivery of SUNOSI 150 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SUNOSI 150 MG TABLET 30S, a non-set-aside procurement with a ceiling value of $2,310.01. The firm fixed-price delivery order has a performance period ending on May 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SUNOSI 150 MG TABLET 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order, valued at $1,555.35, has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order, valued at $3,314.95, is for the supply of 75 mg SUNOSI tablets (national stock number 4565618399). The award has a firm fixed price and the ultimate completion date is August 29, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP60J
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,958.70, is for the delivery of 150 mg Sunosi tablets over the period ending July 31, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 1:32 PM